Tech Company Financing Transactions
Optherion Funding Round
Optherion secured a $5 million venture capital round on 3/31/2009. Investors included Domain Associates and Quaker Partners.
Transaction Overview
Company Name
Announced On
3/31/2009
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Domain Associates (Brian Halak)
Quaker Partners (Sherrill Neff)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
555 Long Wharf Drive 11th Floor
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Overview
Optherion, Inc. is an early-stage biotechnology company that is developing diagnostic and disease-modifying products for the management and treatment of dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system.Optherion's intellectual properties are based on recent scientific discoveries linking certain genes to AMD.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colin Foster
Browse more venture capital transactions:
Prev: 3/31/2009: BitTorrent venture capital transaction
Next: 3/31/2009: Sonexa Therapeutics venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs